195 related articles for article (PubMed ID: 36513625)
1. A diagnosis of Birt-Hogg-Dubé syndrome in individuals with Smith-Magenis syndrome: Recommendation for cancer screening.
Vocke CD; Fleming LR; Piskorski AM; Amin A; Phornphutkul C; de la Monte S; Vilboux T; Duncan F; Pellegrino J; Braddock B; Middelton LA; Schmidt LS; Merino MJ; Cowen EW; Introne WJ; Linehan WM; Smith ACM
Am J Med Genet A; 2023 Feb; 191(2):490-497. PubMed ID: 36513625
[TBL] [Abstract][Full Text] [Related]
2. Bilateral renal tumors in an adult man with Smith-Magenis syndrome: The role of the FLCN gene.
Dardour L; Verleyen P; Lesage K; Holvoet M; Devriendt K
Eur J Med Genet; 2016 Oct; 59(10):499-501. PubMed ID: 27633572
[TBL] [Abstract][Full Text] [Related]
3. Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of FLCN Detected in Patients With Renal Cancer and Thyroid Cancer.
Dong L; Gao M; Hao WJ; Zheng XQ; Li YG; Li XL; Yu Y
Medicine (Baltimore); 2016 May; 95(22):e3695. PubMed ID: 27258496
[TBL] [Abstract][Full Text] [Related]
4. Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas.
Näf E; Laubscher D; Hopfer H; Streit M; Matyas G
Fam Cancer; 2016 Jan; 15(1):127-32. PubMed ID: 26342594
[TBL] [Abstract][Full Text] [Related]
5. Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families.
Houweling AC; Gijezen LM; Jonker MA; van Doorn MB; Oldenburg RA; van Spaendonck-Zwarts KY; Leter EM; van Os TA; van Grieken NC; Jaspars EH; de Jong MM; Bongers EM; Johannesma PC; Postmus PE; van Moorselaar RJ; van Waesberghe JH; Starink TM; van Steensel MA; Gille JJ; Menko FH
Br J Cancer; 2011 Dec; 105(12):1912-9. PubMed ID: 22146830
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of BHD-F59RSVT, an immortalized cell line derived from a renal cell carcinoma in a patient with Birt-Hogg-Dubé syndrome.
Furuya M; Hasumi H; Baba M; Tanaka R; Iribe Y; Onishi T; Nagashima Y; Nakatani Y; Isono Y; Yao M
Lab Invest; 2017 Mar; 97(3):343-351. PubMed ID: 27991910
[TBL] [Abstract][Full Text] [Related]
7. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
[TBL] [Abstract][Full Text] [Related]
9. Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dubé syndrome.
Furuya M; Yao M; Tanaka R; Nagashima Y; Kuroda N; Hasumi H; Baba M; Matsushima J; Nomura F; Nakatani Y
Clin Genet; 2016 Nov; 90(5):403-412. PubMed ID: 27220747
[TBL] [Abstract][Full Text] [Related]
10. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
[TBL] [Abstract][Full Text] [Related]
11. Heterozygous germline FLCN mutation in Birt-Hogg-Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report.
Li J; Liu F; Liu X; Hu Y; Liu Z; Shen Y; Wan J
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2319-2325. PubMed ID: 36258004
[TBL] [Abstract][Full Text] [Related]
12. A case of Birt-Hogg-Dubé syndrome implying reduced or no wild-type folliculin without mutated protein is pathogenic.
Enomoto Y; Namba Y; Hoshika Y; Komemushi Y; Mitani K; Kume H; Kobayashi E; Miyama Y; Homma Y; Ushiku T; Seyama K
Eur J Med Genet; 2020 Apr; 63(4):103820. PubMed ID: 31778855
[TBL] [Abstract][Full Text] [Related]
13. Birt-Hogg-Dubé Syndrome: A Review of Dermatological Manifestations and Other Symptoms.
Tong Y; Schneider JA; Coda AB; Hata TR; Cohen PR
Am J Clin Dermatol; 2018 Feb; 19(1):87-101. PubMed ID: 28695430
[TBL] [Abstract][Full Text] [Related]
14. [Birt-Hogg-Dubé syndrome: an update].
López V; Jordá E; Monteagudo C
Actas Dermosifiliogr; 2012 Apr; 103(3):198-206. PubMed ID: 21937013
[TBL] [Abstract][Full Text] [Related]
15. [Are multiple trichodiscomas/fibrofolliculomas the Birt-Hogg-Dubé syndrome?].
Belousova IE; Shpilyuk RG; Chepushtanova KO; Gorbunov YG; Kazakov DV
Arkh Patol; 2021; 83(3):45-51. PubMed ID: 34041896
[TBL] [Abstract][Full Text] [Related]
16. Delayed diagnosis of Birt-Hogg-Dubé syndrome due to marked intrafamilial clinical variability: a case report.
Sattler EC; Steinlein OK
BMC Med Genet; 2018 Mar; 19(1):45. PubMed ID: 29548312
[TBL] [Abstract][Full Text] [Related]
17. Pathology of Birt-Hogg-Dubé syndrome: A special reference of pulmonary manifestations in a Japanese population with a comprehensive analysis and review.
Furuya M; Nakatani Y
Pathol Int; 2019 Jan; 69(1):1-12. PubMed ID: 30632664
[TBL] [Abstract][Full Text] [Related]
18. Novel germline mutations in FLCN gene identified in two Chinese patients with Birt-Hogg-Dubé syndrome.
Li T; Ning X; He Q; Gong K
Chin J Cancer; 2017 Jan; 36(1):4. PubMed ID: 28069055
[TBL] [Abstract][Full Text] [Related]
19. Birt-Hogg-Dubé Syndrome.
Gupta N; Sunwoo BY; Kotloff RM
Clin Chest Med; 2016 Sep; 37(3):475-86. PubMed ID: 27514594
[TBL] [Abstract][Full Text] [Related]
20. Frequency of truncating FLCN variants and Birt-Hogg-Dubé-associated phenotypes in a health care system population.
Savatt JM; Shimelis H; Moreno-De-Luca A; Strande NT; Oetjens MT; Ledbetter DH; Martin CL; Myers SM; Finucane BM
Genet Med; 2022 Sep; 24(9):1857-1866. PubMed ID: 35639097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]